Cargando…
Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy
Cylindromatosis (CYLD) is a tumor suppressor that regulates signaling pathways by acting as a deubiquitinating enzyme. CYLDdown-regulation occurred in several malignancies, with tumor-promoting effects. Although we found loss of CYLD expression in hypoxic regions of human glioblastoma multiforme (GB...
Autores principales: | Guo, Jianying, Shinriki, Satoru, Su, Yu, Nakamura, Takuya, Hayashi, Mitsuhiro, Tsuda, Yukimoto, Murakami, Yoshitaka, Tasaki, Masayoshi, Hide, Takuichiro, Takezaki, Tatsuya, Kuratsu, Jun-ichi, Yamashita, Satoshi, Ueda, Mitsuharu, Li, Jian-Dong, Ando, Yukio, Jono, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171635/ https://www.ncbi.nlm.nih.gov/pubmed/25071012 |
Ejemplares similares
-
The cylindromatosis (CYLD) gene and head and neck tumorigenesis
por: Verhoeft, Krista Roberta, et al.
Publicado: (2016) -
Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis
por: van den Ouweland, Ans M. W., et al.
Publicado: (2010) -
The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate Notch signalling
por: Rajan, Neil, et al.
Publicado: (2014) -
Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells
por: Nakamura, Takuya, et al.
Publicado: (2014) -
The Tumour Suppressor CYLD Is Required for Clathrin-Mediated Endocytosis of EGFR and Cetuximab-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma
por: Liu, Rin, et al.
Publicado: (2021)